Explore key insights from ASCO 2025 in this thought-provoking article from pharmaphorum, featuring reflections from IQVIA Biotech's oncology leaders. The piece highlights a powerful shift in cancer care—from reactive treatment to proactive, personalized strategies that prioritize earlier intervention and innovation.

Discover how cutting-edge approaches are transforming oncology and what this means for patients, providers, and the future of care.